Description: A man talks on-screen about the dangers of high cholesterol that may cause plaque buildup. He then invites viewers to visit Arterytour.com to get additional information via their interactive online tour. Arterytour.com is a comprehensive sales-pitch site for Crestor. Whats new about this site is that it uses a form of augmented reality to educate people about high cholesterol and plaque buildup.

Click here to visit the site.

To see all of the ads from this campaign, click here

Brand name: Crestor
Generic name/category: Rosuvastatin, statins
Company: AstraZeneca
Country/Market: USA, North America
Indication(s)/use: high LDL cholesterol (dyslipidemia), total cholesterol (hypercholesterolemia) and/or triglycerides (hypertriglyceridemia)
Target: Consumer (DTC)
Medium: TV commercial
Size/duration: 60 seconds
Publication: 2009

To see all Crestor ads, click here

From Wikipedia:
Rosuvastatin is a member of the drug class of statins, used to treat high cholesterol and related conditions, and to prevent cardiovascular disease. Shionogi developed the product and the pharmaceutical company AstraZeneca markets it as Crestor.

Rosuvastatin is approved for the treatment of high LDL cholesterol (dyslipidemia), total cholesterol (hypercholesterolemia) and/or triglycerides (hypertriglyceridemia).

As of 2004, rosuvastatin had been approved in 154 countries and launched in 56. Approval in the United States by the FDA came on August 12, 2003.

More on Wikipedia

Click here to see the details and full-size version of this ad on AdPharm

This ad and thousands more can be seen on the AdPharm gallery, the largest online pharmaceutical advertising gallery.

Learn about high cholesterol and plaque buildup. Take an interactive artery tour.

Description: This is a very elaborate site on the risks associated with high cholesterol and plaque buildup. It also is a comprehensive sales-pitch for Crestor. Whats new about this Crestor site is that it uses a form of augmented reality to educate people about high cholesterol and plaque buildup.

Click here to visit the site.

To see all of the ads from this campaign, click here

Brand name: Crestor
Generic name/category: Rosuvastatin, statins
Company: AstraZeneca
Country/Market: USA, North America
Indication(s)/use: high LDL cholesterol (dyslipidemia), total cholesterol (hypercholesterolemia) and/or triglycerides (hypertriglyceridemia)
Target: Consumer (DTC)
Medium: Internet
Publication: 2009

To see all Crestor ads, click here

From Wikipedia:
Rosuvastatin is a member of the drug class of statins, used to treat high cholesterol and related conditions, and to prevent cardiovascular disease. Shionogi developed the product and the pharmaceutical company AstraZeneca markets it as Crestor.

Rosuvastatin is approved for the treatment of high LDL cholesterol (dyslipidemia), total cholesterol (hypercholesterolemia) and/or triglycerides (hypertriglyceridemia).

As of 2004, rosuvastatin had been approved in 154 countries and launched in 56. Approval in the United States by the FDA came on August 12, 2003.

More on Wikipedia

Click here to see the details and full-size version of this ad on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

Description: People from different walks of life talk about cholesterol and how much they thought they knew about it and in reality they don’t. A spokesperson then comes in and talks about the risks associated with high cholesterol and its link with plaque buildup using animated visuals…

To see all of the ads from this campaign, click here

Brand name: Crestor
Generic name/category: Rosuvastatin, statins
Company: AstraZeneca
Country/Market: USA, North America
Indication(s)/use: high LDL cholesterol (dyslipidemia), total cholesterol (hypercholesterolemia) and/or triglycerides (hypertriglyceridemia)
Target: Consumer (DTC)
Medium: TV commercial
Size/duration: 60 seconds
Publication: 2009

To see all Crestor ads, click here

From Wikipedia:
Rosuvastatin is a member of the drug class of statins, used to treat high cholesterol and related conditions, and to prevent cardiovascular disease. Shionogi developed the product and the pharmaceutical company AstraZeneca markets it as Crestor.

Rosuvastatin is approved for the treatment of high LDL cholesterol (dyslipidemia), total cholesterol (hypercholesterolemia) and/or triglycerides (hypertriglyceridemia).

As of 2004, rosuvastatin had been approved in 154 countries and launched in 56. Approval in the United States by the FDA came on August 12, 2003.

More on Wikipedia

Click here to see the details and full-size version of this ad on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

Shouldn’t you be trying something like this to help your heart’s arteries?

Consider Niaspan. For patients with high cholesterol and plaque in the arteries of the heart, Niaspan, along with diet and another cholesterol medication (colestipol), is FDA-approved to not only slow down plaque buildup, but also help reduce the plaque that’s already ther

Ask your doctor if Niaspan is right for you.
Tear our this ad. Take it to your doctor. Ask if you should be doing something about plaque.

To view the ad, click here

Brand name: Niaspan
Generic name/category: Niacin, Hypolipidemic agents
Company: Abbott
Country/Market: USA, North America
Indication(s)/use: lower high cholesterol and reduce plaque
Target: Consumers (DTC)
Medium: Print ad
Size/duration: double-page spread
Publication/Aired: Heart-healthy Living – Fall 2009

Everyday food & drink acids can cause irreversible loss of your tooth enamel.

Save your enamel. Because once its gone, it can be gone for good. Try new Crest Pro-Heath Enamel Shield.

Brand name: Crest Pro-health

Generic name/category: Toothpaste
Company: Crest
Country/Market: USA, North America
Indication(s)/use: Protection of teeth enamel, Fights cavities, tartar, sensitivity, plaque, gingivitis, teeth whitener, Freshens breath
Target: Consumers (DTC)
Tagline: Healthy, Beautiful Smiles for Life.
Medium: Print ad
Size/duration: single-page
Publication/Aired: Working Mother – August/September 2009

To see all of this brand’s ads on AdPharm, click here

Visit AdPharm.net for more pharmaceutical ads

For adults with chronic moderate to severe plaque psoriasis
Clearer skin in 3 months

Before Enbrel. An example of one skin area. After Enbrel. Your results may vary.
Example of approximately 75% skin clearance.

If you and your doctor decide that Enbrel is right for you, ask about the Enbrel support co-pay program.
No co-pay for 6 months for eligible patients.

Ask your dermatologist if Enbrel is right for you. Learn more: visit enbrel.com or call 1-888-4ENBREL.

Brand name: Enbrel
Generic name/category: Etanercept, TNF inhibitor
Company: Amgen and Wyeth
Country/Market: USA, North America
Indication(s)/use: Moderate to severe chronic plaque psoriasis (PsA)
Target: Consumers (DTC)
Publication: People Magazine June 15 2009

To see all of this brand’s ads, click here

Amevive is the biologic that gives patients the longest breaks between treatment courses.

Alefacept is a genetically engineered immunosuppressive drug sold under the brand name Amevive in Canada, the United States, Israel, Switzerland and Australia. It is used to control inflammation in moderate to severe psoriasis with plaque formation, where it interferes with lymphocyte activation. It is also being studied in the treatment of cutaneous T-cell lymphoma and T-cell non-Hodgkin lymphoma.

Alefacept is a fusion protein: it combines part of an antibody with a protein that blocks the growth of some types of T cells. – Wikipedia

Agency: AbelsonTaylor
Creative Director-art: Therese Maginot
Creative Director-copy: Barry Levine
Art Director: Angie Bauerle
Copywriter: Mike Fine
RXClub 2008 Silver Award Winner

More Amevive and inflammation ads on AdPharm